Korean J Pediatr Search

CLOSE


Korean J Pediatr > Volume 60(10); 2017 > Article
Choi and Song: Fetal and preterm infant microbiomes: a new perspective of necrotizing enterocolitis

Abstract

Necrotizing enterocolitis (NEC) is a devastating condition of hospitalized preterm infants. Numerous studies have attempted to identify the cause of NEC by examining the immunological features associated with pathogenic microorganisms. No single organism has proven responsible for the disease; however, immunological studies are now focused on the microbiome. Recent research has investigated the numerous bacterial species residing in the body and their role in diseases in preterm infants. The timing of initial microbial colonization is a subject of interest. The microbiome appears to transfer from the mother to the newborn, as well as to the fetus. Cross-talk between the fetus and fetal microbiome takes place continuously to generate a unique immune system. This review examined the transfer of the microbiome to the human fetus, and its potential relationship with NEC.

Introduction

To date, research to increase our understanding of the extensive profiles of microorganisms has been limited. However, the emergence of nonculture sequencing techniques combined with bioinformatics has allowed scientists to better understand the entire microbiome in humans, furthermore, even in the ocean and soil1). The Human Microbiome Project Consortium2) has described the structure, function, and diversity of the microbiome in healthy people in their 2012's report. Humans have remarkably diverse microbiomes in their gut, skin, and vagina. Mammals, including humans, have vast amount of gut surface area, an ideal environment for gut commensals. More than 100 trillion microbes reside in the human gut and continuously interact with the host, resulting in individual immune mutualism, a condition beneficial to both. Microbes exist in homeostasis as commensals, which the host not only tolerates, but also evolves with, to ensure enrichment of beneficial microorganisms3). The primary function of the microbiota is protection, including pathogen displacement, nutrient competition, and production of antimicrobial factors such as bacteriocins or lactic acid. Secondary functions include barrier fortification, induction of IgA, and control of intestinal epithelial cell (IEC) differentiation4).

The microbiome in the human fetus

As the womb has traditionally been considered sterile, an ascending infection from the cervix or vagina could cause adverse events, such as preterm labor5,6). For more than a century, the paradigm was that any bacteria in the womb would be pathologic; therefore, few studies investigated bacteria in a normal, healthy pregnancy. Today, however, high-throughput technology (e.g., 16S ribosomal RNA pyrosequencing or whole-genome-shotgun technique) has made it possible to identify the complete inventory of microbes in the human body. Interestingly, however, the dogma of a germ-free environment within the womb is still maintained. For example, Weng and Walker7), in a recent review, considered the role of the microbiota in immune phenotype programing based on the belief that the acquisition of the microbiota starts when the fetus emerges from the womb. However, recent evidence tells us that the womb is in fact not germ-free8). Because the placenta has been deemed a barrier against pathologic bacteria, it is surprising that the placenta harbors a unique microbiome in healthy, pregnant women9).
Conventional polymerase chain reaction studies in the past decade sporadically identified bacteria in umbilical cord blood during a healthy pregnancy10), as well as in the meconium of normal, healthy infants11). The polymerase chain reaction method also revealed that the placental membrane contained microbes12), including Bifidobacterium and Lactobacillus spp.13). High-throughput analysis has only recently revealed the existence of various dense microbiome communities in the fetus. As neither the amniotic fluid or placenta are sterile, it is assumed that colonization starts during fetal life14,15). Some researchers have presented evidence of placental microbes which may lead to preterm labor and preeclampsia16,17).
In the era of next-generation sequencing, Aagaard et al.14) analyzed placental commensalism using whole-genome shotgun metagenomics. They found unique placental microbiome commensalism that included bacteria from various phyla, such as Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes, and Fusobacteria. When compared to the maternal microbiomes (oral cavity, gut, cervix, and vagina), the fetal meconium microbiome is more similar to the maternal oral cavity than the vagina. Therefore, it is inferred that bacteria from the mother's oral cavity translocate into the blood stream, then to the placenta, and finally into the fetus (Fig. 1). The traditional ascending pathway from the cervix into the uterus might be limited to pathologic conditions such as chorioamnionitis or early-onset neonatal sepsis. Collado et al.15) found that the amniotic fluid and placental microbiomes were similar in composition. In order to eliminate birth canal contamination, they included cesarean section cases only. Enterobacter, Escherichia, Shigella, and Propionibacterium spp. were dominant. Again, we can infer from these findings that microbes might invade through the IECs, such as dendritic cells, move first to the blood stream, then reach lymphoid tissue, and finally the placenta18). An animal experiment showed that during pregnancy, a 60% increase in intestinal microbes is found in lymph nodes19).

Newborn colonization

Soon after birth, several factors contribute to the initial colonization of the neonatal gut. These include delivery type, breast milk feeding, and antibiotic exposure; caesarean section is associated with decreased microbial diversity and abundance20), breast milk feeding promotes a balanced microbial community and aids in gut development in infants21,22), and antibiotic exposures destroy the normal composition of commensalism23). For preterm infants and full term newborns, breastfeeding or breast milk is strongly recommended for various reasons24). The preventive effect of maternal breast milk against NEC development is specifically true for preterm infants25). Factors in human milk such as immunoglobulins work to protect against hazardous organisms, a passive mechanism from the infant's perspective. In contrast, some factors actively influence the infant immune system, e.g., oligosaccharides as immune modulators26).
Gregory et al.21) recently conducted a study on the role of breast milk ingestion on acquisition of the intestinal microbiome in preterm infants. The preterm infant gut microbiome was greatly influenced by breast milk. Postnatal time, birth weight, gestational age, and nutrition affected the microbial type and diversity. Cong et al.22) stressed similar points, but found that patterns differed between maternal milk-fed infants and those fed human donor milk. Maternal milk conferred optimal balance to the infant microbiome community. The transmission from mother to infant is accomplished by both external and internal transfer. Of course, the flora from the areolar area also contribute numerous microbiota to the newborn. However, the internal breast tissue also harbors microbes that can be transferred. There may be an entero-mammary pathway by which the maternal gut microbiota also transfer to the newborn18).

Microbial role in NEC development

NEC is a major complication in 10% of very low birth weight infants27). The precise mechanism of NEC development is not fully understood. Clinically, diagnosing NEC has definite limitations. Bell's criteria for NEC were first described in the 1970s, when most NEC cases presented in full-term infants28). However, NEC currently targets preterm infants. Furthermore, although the modified Bell's criteria removed Stage I disease in order to eliminate possible overlap with other conditions, the criteria still include sepsis and spontaneous intestinal perforation, as well as NEC itself29). When is the gut most prone to be affected by NEC? What is the most common causative organism? In the early 1990s, Lucas and Cole30) found that exclusively formula-fed infants had 6 to 10 times greater risk of developing NEC. In particular, infants older than 30 weeks of postmenstrual age seldom had the disease. Although this study was published 27 years ago, it is compatible with recent data from the microbiome era. Neu and Pammi31), in a recent review article, briefly discussed unpublished data about NEC incidence. Interestingly, the incidence peaks at 31 weeks of postconceptual age. This is an intriguing finding because it suggests that there must be a certain association between preterm infant gut developmental status and NEC. In other words, it occurs when the gut is ready.
There are numerous recent studies regarding microbial patterns and NEC development. According to one recent meta-analysis32), there is no single causative bacterial agent, but instead a consistent microbiome pattern, that precedes NEC. The pattern is associated with decreased relative abundance of Firmicutes and Bacteroidetes, but increased numbers of Proteobacteria; these findings are associated with strikingly decreased microbial diversity in infants with NEC. These patterns can be considered to reflect “dysbiosis.” This refers to a change from normal, healthy colonization to pathologic conditions. Firmicutes, Bacteroidetes, and Proteobacteria may create an imbalance in intestinal immunity as a result of antibiotic exposure, which results in both an increased risk of NEC and dysbiosis in the gut. The antibiotic exposure group displayed an increased abundance of Klebsiella, Enterobacteriaceae, Proteus, Paenibacillus, Epulopiscium, and Pseudomonas32).
IECs and gut-associated lymphoid tissue constantly interact with microbiota in the lumen. A microbiome-associated molecular pattern (MAMP) stimulates pathogen-recognition receptors that trigger various patterns of immune phenotypes. Dysbiosis dysregulates gut immunity in preterm newborns and eventually results in major morbidities, usually by precipitating proinflammatory reactions. There is abundant evidence for the contribution of the microbiome to a proinflammatory state and NEC development.
(1) A bowel in which Bacteroidetes are decreased secretes a higher level of inflammatory cytokines such as interleukin-633).
(2) The myeloid differentiation primary response gene 88 (MYD-88) is one of 4 immediate adapter molecules that mediate Toll-like receptor (TLR)-MAMP engagement. It is essential for the perception of MAMP and presentation to TLR. When TLR-MYD88 expression is down-regulated, infants are more susceptible to serious infection34). Excessive TLR4 signaling regulates apoptosis, proliferation, and migration of enterocytes, microcirculatory perfusion, and other effects. Normal commensal bacteria exploit TLRs to maintain homeostasis35), but excessive TLR4 expression in dysbiotic intestine can result in NEC36).
(3) Germ-free mice were investigated to determine how the immune system is altered. They showed a decreased level of CD4, CD8, and secretory IgA37,38).
(4) IgA is essential for the maturation of gut immunity. The host gut and commensal microbiota regulate the polymeric immunoglobulin receptor through MAMP. This is regulated by the original colonizing flora. There is evidence that IgA deficiency induces an increase in Proteobacteria39) and that Proteobacteria-specific IgA is responsible for NEC40).
(5) Colonization also influences immune tolerance. Bifidobacterium infantis suppresses the Th2 response to generate oral tolerance in germ-free newborn mice41).

Bacterial diversity and NEC

The intestine is the organ most exposed to macro- and micromolecules and bacteria. Whether lower or higher bacterial diversity exists in NEC is yet to be determined. However, evidence of the former predominates42,43,44). McMurtry et al.45) examined the influence of the microbiome on NEC and found that bacterial diversity was significantly lower in the NEC group. Furthermore, they reviewed subgroup analysis and found a tendency toward a decreasing Shannon index with increasing severity. Microbial diversity in a metagenomic study can be expressed as the Shannon diversity index. This is a quantitative measurement of how many species are present in a specimen. As mentioned above, the fetus shows diverse commensalism in the womb. Disequilibrium affects gut immunity and predisposes to NEC and other diseases.

Microbiome-related epigenetics

Recently, epigenomic studies have been applied to characterize the origins of preterm infant morbidities. Epigenetic mechanisms generate new phenotypic traits. The process takes place during both the prenatal and postnatal period, mainly via DNA or histone modification through enzymatic methylation processes or incorporation of foreign genes. This changes the traits in nuclear architecture so that remodeling of gene expression occurs. Epigenetics are responsible for the development of metabolic syndromes in later adolescent life of intrauterine growth restriction infants through a acquiprocess known as fetal programing46). It mainly involves insulin resistance in these individuals. Additionally, it also involves a gut-microbiota interaction, the “cross-talk.” It deals with preterm birth itself47), infant neurodevelopment48,49), and pulmonary outcomes50). It also confers definite inflammatory traits in the intestine in preterm infants, and can result in high susceptibility to NEC. Remarkably, the prenatal process persists during the postnatal period51). Several studies have shown definitive evidence that colonizing microbiota might induce epigenetic changes48,52). Furthermore, enteral feeding during the Newborn Intensive Care Unit stay greatly influences the gut-microbiota interaction. This epigenome-microbiome cross-talk might be a key player in the development of NEC and other preterm infant morbidities.
Cortese et al.53) demonstrated that probiotic bacteria such as Lactobacillus acidophilus and B. infantis rather than Gammaproteobacteria, such as Klebsiella spp. induced different DNA modifications in a human IEC line experiment. The Klebsiella spp.-treated group showed overrepresented cytoskeleton remodeling. These changes were more sensitive in fetal cell lines than in adult cell lines. They revealed that antenatal corticosteroid resulted in an altered TLR pathway in association with the microbiome. This is quite an impressive finding because the cross-talk takes place very actively in fetal gut to affect individual DNA modification. A typical example of fetal epigenome change is intrauterine growth restriction and insulin resistance. Therefore, future studies investigating host-microbiome interactions in intrauterine growth restriction might be valuable.

Conclusion

The emergence of next-generation pyrosequencing of 16S rRNA has facilitated our ability to analyze microbes in the placenta, cord blood, amniotic fluid, fetal meconium, maternal gastrointestinal tract and mammary gland. The unique and intriguing journey of microbes between a pregnant woman and the fetus is still unclear, however many immunological and epigenetic hypotheses and findings are now being published. Germs continue to cross-talk with the host to form specific individual phenotypes. The cross-talk takes place in the fetus as well as in the preterm infant gut. There is evidence that microbiomes utilize various molecules and DNA to maintain homeostasis; therefore, dysbiosis contributes to the development of NEC in preterm infants.

Notes

Conflict of interest:
No potential conflict of interest relevant to this article was reported.

References

1. Gilbert JA, Dupont CL. Microbial metagenomics: beyond the genome. Ann Rev Mar Sci 2011;3:347–371.
crossref pmid
2. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207–214.
crossref pmid pmc
3. Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK. Host-bacterial symbiosis in health and disease. Adv Immunol 2010;107:243–274.
crossref pmid pmc
4. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006;7:688–693.
crossref pmid pmc
5. Gonçalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002;8:3–13.
crossref pmid
6. Madianos PN, Bobetsis YA, Offenbacher S. Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms. J Periodontol 2013;84(4 Suppl): S170–S180.
crossref pmid
7. Weng M, Walker WA. The role of gut microbiota in programming the immune phenotype. J Dev Orig Health Dis 2013;4:203–214.
crossref pmid
8. Perez-Muñoz ME, Arrieta MC, Ramer-Tait AE, Walter J. A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome 2017;5:48
crossref pmid pmc
9. Prince AL, Antony KM, Chu DM, Aagaard KM. The microbiome, parturition, and timing of birth: more questions than answers. J Reprod Immunol 2014;104-105:12–19.
crossref pmid
10. Jiménez E, Fernández L, Marín ML, Martín R, Odriozola JM, Nueno-Palop C, et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol 2005;51:270–274.
crossref pmid
11. Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy newborns actually sterile. Res Microbiol 2008;159:187–193.
crossref pmid
12. Jones HE, Harris KA, Azizia M, Bank L, Carpenter B, Hartley JC, et al. Differing prevalence and diversity of bacterial species in fetal membranes from very preterm and term labor. PLoS One 2009;4:e8205.
crossref pmid pmc
13. Satokari R, Grönroos T, Laitinen K, Salminen S, Isolauri E. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol 2009;48:8–12.
crossref pmid
14. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014;6:237ra65.
crossref pmid pmc
15. Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep 2016;6:23129.
crossref pmid pmc
16. Doyle RM, Alber DG, Jones HE, Harris K, Fitzgerald F, Peebles D, et al. Term and preterm labour are associated with distinct microbial community structures in placental membranes which are independent of mode of delivery. Placenta 2014;35:1099–1101.
crossref pmid
17. Amarasekara R, Jayasekara RW, Senanayake H, Dissanayake VH. Microbiome of the placenta in pre-eclampsia supports the role of bacteria in the multifactorial cause of pre-eclampsia. J Obstet Gynaecol Res 2015;41:662–669.
crossref pmid
18. Funkhouser LJ, Bordenstein SR. Mom knows best: the universality of maternal microbial transmission. PLoS Biol 2013;11:e1001631.
crossref pmid pmc
19. Perez PF, Doré J, Leclerc M, Levenez F, Benyacoub J, Serrant P, et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics 2007;119:e724–e732.
crossref pmid
20. Rutayisire E, Huang K, Liu Y, Tao F. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review. BMC Gastroenterol 2016;16:86
crossref pmid pmc
21. Gregory KE, Samuel BS, Houghteling P, Shan G, Ausubel FM, Sadreyev RI, et al. Influence of maternal breast milk ingestion on acquisition of the intestinal microbiome in preterm infants. Microbiome 2016;4:68
crossref pmid pmc
22. Cong X, Judge M, Xu W, Diallo A, Janton S, Brownell EA, et al. Influence of feeding type on gut microbiome development in hospitalized preterm infants. Nurs Res 2017;66:123–133.
crossref pmid pmc
23. Zeissig S, Blumberg RS. Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease. Nat Immunol 2014;15:307–310.
crossref pmid
24. ESPGHAN Committee on Nutrition; Agostoni C, Braegger C, Decsi T, Kolacek S, Koletzko B, et al. Breast-feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2009;49:112–125.
crossref pmid
25. McGuire W, Anthony MY. Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed 2003;88:F11–F14.
crossref pmid pmc
26. Rautava S, Walker WA. Academy of Breastfeeding Medicine founder's lecture 2008: breastfeeding--an extrauterine link between mother and child. Breastfeed Med 2009;4:3–10.
crossref pmid pmc
27. Patel RM, Kandefer S, Walsh MC, Bell EF, Carlo WA, Laptook AR, et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 2015;372:331–340.
crossref pmid pmc
28. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1–7.
crossref pmid pmc
29. Gordon P, Christensen R, Weitkamp JH, Maheshwari A. Mapping the New World of Necrotizing Enterocolitis (NEC): Review and Opinion. EJ Neonatol Res 2012;2:145–172.
pmid pmc
30. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336:1519–1523.
crossref pmid
31. Neu J, Pammi M. Pathogenesis of NEC: Impact of an altered intestinal microbiome. Semin Perinatol 2017;41:29–35.
crossref pmid
32. Pammi M, Cope J, Tarr PI, Warner BB, Morrow AL, Mai V, et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome 2017;5:31.
crossref pmid pmc
33. Sjögren YM, Tomicic S, Lundberg A, Böttcher MF, Björkstén B, Sverremark-Ekström E, et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy 2009;39:1842–1851.
crossref pmid
34. Singh VV, Chauhan SK, Rai R, Kumar A, Rai G. Decreased toll-like receptor-4/myeloid differentiation factor 88 response leads to defective interleukin-1β production in term low birth weight newborns. Pediatr Infect Dis J 2014;33:1270–1276.
crossref pmid
35. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229–241.
crossref pmid
36. Lu P, Sodhi CP, Hackam DJ. Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis. Pathophysiology 2014;21:81–93.
crossref pmid
37. Jiang HQ, Thurnheer MC, Zuercher AW, Boiko NV, Bos NA, Cebra JJ. Interactions of commensal gut microbes with subsets of B- and T-cells in the murine host. Vaccine 2004;22:805–811.
crossref pmid
38. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012;149:1578–1593.
crossref pmid pmc
39. Johansen FE, Kaetzel CS. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol 2011;4:598–602.
crossref pmid pmc
40. Mirpuri J, Raetz M, Sturge CR, Wilhelm CL, Benson A, Savani RC, et al. Proteobacteria-specific IgA regulates maturation of the intestinal microbiota. Gut Microbes 2014;5:28–39.
crossref pmid
41. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739–1745.
pmid
42. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009;3:944–954.
crossref pmid pmc
43. Morrow AL, Lagomarcino AJ, Schibler KR, Taft DH, Yu Z, Wang B, et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome 2013;1:13
crossref pmid pmc
44. Hourigan SK, Ta A, Wong WS, Clemency NC, Provenzano MG, Baveja R, et al. The microbiome in necrotizing enterocolitis: a case report in twins and minireview. Clin Ther 2016;38:747–753.
crossref pmid
45. McMurtry VE, Gupta RW, Tran L, Blanchard EE 4th, Penn D, Taylor CM, et al. Bacterial diversity and Clostridia abundance decrease with increasing severity of necrotizing enterocolitis. Microbiome 2015;3:11.
crossref pmid pmc
46. Sookoian S, Gianotti TF, Burgueño AL, Pirola CJ. Fetal metabolic programming and epigenetic modifications: a systems biology approach. Pediatr Res 2013;73(4 Pt 2): 531–542.
crossref pmid
47. Toure DM, ElRayes W, Barnes-Josiah D, Hartman T, Klinkebiel D, Baccaglini L. Epigenetic modifications of human placenta associated with preterm birth: a systematic review. J Matern Fetal Neonatal Med 2017;1. –12. [Epub].

48. Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain & behaviour-epigenetic regulation of the gut-brain axis. Genes Brain Behav 2014;13:69–86.
crossref pmid
49. Yiu TT, Li W. Pediatric cancer epigenome and the influence of folate. Epigenomics 2015;7:961–973.
crossref pmid pmc
50. Hagood JS. Beyond the genome: epigenetic mechanisms in lung remodeling. Physiology (Bethesda) 2014;29:177–185.
pmid pmc
51. Gao F, Zhang J, Jiang P, Gong D, Wang JW, Xia Y, et al. Marked methylation changes in intestinal genes during the perinatal period of preterm neonates. BMC Genomics 2014;15:716.
crossref pmid pmc
52. Kumar H, Lund R, Laiho A, Lundelin K, Ley RE, Isolauri E, et al. Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio 2014;5:e02113–e02114.
pmid pmc
53. Cortese R, Lu L, Yu Y, Ruden D, Claud EC. Epigenome-Microbiome crosstalk: A potential new paradigm influencing neonatal susceptibility to disease. Epigenetics 2016;11:205–215.
crossref pmid pmc
Fig. 1

Schematic of the microbiome journey between mother and fetus: 1, Oral cavity flora move to the intestine to form a microbial community; 2, The microbiome congregates in gut-associated lymphoid tissue to stream in the blood, and finally harbor in the placenta; 3, The gut microbiome travel in the same manner to reach the mammary gland. The entero-mammary pathway passes the maternal gut microbiome to the newborn when it feeds on breast milk.

kjped-60-307-g001.jpg


ABOUT
TOPICS

Browse all articles >

ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
#1606 Seocho World Officetel, 19 Seoun-ro, Seocho-ku, Seoul 06732, Korea
Tel: +82-2-3473-7305    Fax: +82-2-3473-7307    E-mail: kjpped@gmail.com                

Copyright © 2019 by Korean Pediatric Society. All rights reserved.

Developed in M2community

Close layer
prev next